-
CMAJ : Canadian Medical Association... Dec 2021
Topics: Anti-Bacterial Agents; Canada; Doxycycline; Humans; Lymphogranuloma Venereum; Sexual Partners; Sexually Transmitted Diseases, Bacterial
PubMed: 34903592
DOI: 10.1503/cmaj.210853 -
Sexually Transmitted Diseases Feb 2021
Topics: Chlamydia trachomatis; Homosexuality, Male; Humans; Lymphogranuloma Venereum; Male; Proctitis
PubMed: 32910032
DOI: 10.1097/OLQ.0000000000001285 -
Sexually Transmitted Infections Apr 2002Lymphogranuloma venereum is caused by serovars of Chlamydia trachomatis. It is rare in industrialised countries, but is endemic in parts of Africa, Asia, South America,... (Review)
Review
Lymphogranuloma venereum is caused by serovars of Chlamydia trachomatis. It is rare in industrialised countries, but is endemic in parts of Africa, Asia, South America, and the Caribbean. We discuss its clinical features, diagnosis, and management.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Disease Progression; Humans; Lymphogranuloma Venereum; Male
PubMed: 12081191
DOI: 10.1136/sti.78.2.90 -
Casopis Lekaru Ceskych 2012Lymphogranuloma venereum is a sexually transmitted disease caused by serovars L1-3 of Chlamydia trachomatis. This infection was originally endemic in tropics and... (Review)
Review
Lymphogranuloma venereum is a sexually transmitted disease caused by serovars L1-3 of Chlamydia trachomatis. This infection was originally endemic in tropics and transmitted predominantly by heterosexual contact but since the beginning of the century it spreads in industrialized countries mainly among men having sex with men causing them severe proctitis. In the Czech Republic the first case was diagnosed in 2011. Lymphogranuloma venereum can resemble other forms of anorectal disorders inclusive inflammatory bowel diseases and thus it must be included into differential diagnostic considerations. Definitive diagnosis is based on detection of specific serovars of Chlamydia trachomatis by polymerase chain reaction. In patients with lymphogranuloma venereum it is also necessary to exclude other sexually transmitted diseases, particularly syphilis, HIV and also hepatitis C. The therapy of choice is doxycycline administered for three weeks.
Topics: Diagnosis, Differential; Humans; Lymphogranuloma Venereum
PubMed: 23301587
DOI: No ID Found -
Primary Care Mar 1990Although LGV is a relatively rare sexually transmitted disease in the United States, its aggressive nature and serious late sequelae make early recognition and treatment... (Review)
Review
Although LGV is a relatively rare sexually transmitted disease in the United States, its aggressive nature and serious late sequelae make early recognition and treatment imperative. The course of the disease is divided into three stages: primary genital lesions, secondary inguinal bubo development, and late fistula and stricture formation. Diagnosis is based on the clinical picture and demonstration of C trachomatis inclusion bodies on direct fluorescent antibody staining. The disease responds to tetracycline; 21 days of therapy are recommended.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Female; Humans; Lymphogranuloma Venereum; Male
PubMed: 2181506
DOI: No ID Found -
International Journal of Dermatology 1976
Review
Topics: Adult; Anti-Bacterial Agents; Chlamydia trachomatis; Female; Humans; Lymphogranuloma Venereum; Male; United States
PubMed: 1107239
DOI: 10.1111/j.1365-4362.1976.tb05091.x -
British Medical Bulletin Apr 1983
Review
Topics: Female; Humans; Lymphatic Diseases; Lymphogranuloma Venereum; Male; Proctitis
PubMed: 6347324
DOI: 10.1093/oxfordjournals.bmb.a071807 -
Clinical Gastroenterology and... Dec 2020
Topics: Chlamydia trachomatis; Homosexuality, Male; Humans; Lymphogranuloma Venereum; Male; Proctitis
PubMed: 31843597
DOI: 10.1016/j.cgh.2019.12.009 -
Clinical Gastroenterology and... Jul 2019
Topics: Chlamydia trachomatis; Diagnosis, Differential; Homosexuality, Male; Humans; Lymphogranuloma Venereum; Male; Middle Aged; Proctitis; Rectum; Sigmoidoscopy
PubMed: 30081010
DOI: 10.1016/j.cgh.2018.06.019 -
Journal of the European Academy of... Aug 2021
Topics: Chlamydia trachomatis; Humans; Lymphogranuloma Venereum
PubMed: 34288143
DOI: 10.1111/jdv.17468